10X Genomics Inc TXG:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/13/21 EDT
136.61quote price arrow up+2.39 (+1.78%)
Volume
1,663,863
52 week range
72.04 - 203.25

...

Loading . . .
  • Open136.69
  • Day High140.91
  • Day Low134.68
  • Prev Close136.61
  • 52 Week High203.25
  • 52 Week High Date04/26/21
  • 52 Week Low72.04
  • 52 Week Low Date05/22/20

Key Stats

  • Market Cap15.00B
  • Shares Out109.80M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-3.52

KEY STATS

  • Open136.69
  • Day High140.91
  • Day Low134.68
  • Prev Close136.61
  • 52 Week High203.25
  • 52 Week High Date04/26/21
  • 52 Week Low72.04
  • 52 Week Low Date05/22/20
  • Market Cap15.00B
  • Shares Out109.80M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-3.52

RATIOS/PROFITABILITY

  • EPS (TTM)-5.03
  • P/E (TTM)-27.14
  • Fwd P/E (NTM)-164.00
  • EBITDA (MRQ)-504.999M
  • ROE (MRQ)-91.80%
  • Revenue (MRQ)332.76M
  • Gross Margin (MRQ)81.84%
  • Net Margin (MRQ)-160.22%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On 10X Genomics Inc

There is no recent news for this security.

Profile

MORE
10x Genomics, Inc. is a life science technology company. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The Company’s product consists of chromium single cell gene expression solution, cell immune profiling solution, cell copy number variation (CNV) solution, Cell assay for transposase accessible chromatin (ATAC) solution. The Company’s Chromium...
John Stuelpnagel
Chairman
Serge Saxonov Ph.D.
Chief Executive Officer
Benjamin Hindson
President
Justin McAnear
Chief Financial Officer
Eric Whitaker J.D.
General Counsel
Address
6230 Stoneridge Mall Road
Pleasanton, CA
94588
United States

Top Peers

SYMBOLLASTCHG%CHG
PODD
Insulet Corp
226.02+0.50+0.22%
NVCR
Novocure Ltd
173.04-6.79-3.78%
ABMD
ABIOMED Inc
262.71-9.54-3.50%
RGEN
Repligen Corp
169.65-1.95-1.14%
PEN
Penumbra Inc
240.80-7.01-2.83%